Does Non-Adherence Increase Treatment Costs in Schizophrenia?
Mark W PenningtonPaul McCronePublished in: PharmacoEconomics (2019)
Inference from analysis of administrative data is limited by the risk of selection bias. Inference from trials is limited by small sample sizes. The literature does not consistently support an assumption that non-adherence increases healthcare costs.